Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke
Behavioural Brain Research · 2023
DOI: 10.1016/j.bbr.2023.114471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2023. Verfasst von Neha Dhir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Mesenchymal Stem Cells, Brain Ischemia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Department of Health Research, India, Ministry of Health and Family Welfare.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Stroke, a devastating neurological emergency, is the leading cause of worldwide mortality and functional disability. Combining novel neuroprotective drugs offers a way to improve the stroke intervention outcomes. In the present era, the combination therapy has been proposed as a plausible strategy to target multiple mechanisms and enhance the treatment efficacy to rescue stroke induced behavioral abnormalities and neuropathological damage. In the current study, we have investigated the neuroprotective effect of stiripentol (STP) and trans integrated stress response inhibitor (ISRIB) alone and in combination with rat bone marrow derived mesenchymal stem cells (BM-MSCs) secretome in an experimental model of stroke. MATERIALS & METHODS: Stroke was induced in male Wistar rats (n = 92) by temporary middle cerebral artery occlusion (MCAO). Three investigational agents were selected including STP (350 mg/kg; i.p.), trans ISRIB (2.5 mg/kg; i.p.) and rat BM-MSCs secretome (100 µg/kg; i.v). Treatment was administered at 3 hrs post MCAO, in four doses with a 12 hrs inter-dose interval. Post MCAO, neurological deficits, brain infarct, brain edema, BBB permeability, motor functional and memory deficits were assessed. Molecular parameters: oxidative stress, pro inflammatory cytokines, synaptic protein markers, apoptotic protein markers and histopathological damage were assessed. RESULTS: STP and trans ISRIB, alone and in combination with rat BM-MSCs secretome, significantly improved neurological, motor function and memory deficits along with significant reduction in pyknotic neurons in the brain of post MCAO rats. These results were correlating with significant reduction in pro-inflammatory cytokines, microglial activation and apoptotic markers in the brain of drug treated post MCAO rats. CONCLUSION: STP and trans ISRIB, alone and in combination with rat BM-MSCs secretome, might be considered as potential neuroprotective agents in the acute ischemic stroke (AIS) management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Neurology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
- Department of Pediatrics, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Department of Biochemistry, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India.
- Department of Biophysics, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
- Department of Histopathology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Förderung
- Department of Health Research, India
- Ministry of Health and Family Welfare
Zitieren
APA
Dhir, N., Jain, A., Sharma, A. R., Sharma, S., Mahendru, D., Patial, A., Malik, D., Prakash, A., Attri, S. V., Bhattacharyya, S., Das Radotra, B., & Medhi, B. (2023). Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114471
Vancouver
Dhir N, Jain A, Sharma AR, Sharma S, Mahendru D, Patial A, et al. Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke. Behavioural Brain Research. 2023. doi:10.1016/j.bbr.2023.114471
BibTeX
@article{Dhir2023,
author = {Dhir, Neha and Jain, Ashish and Sharma, Amit Raj and Sharma, Sunil and Mahendru, Dhruv and Patial, Ajay and Malik, Deepti and Prakash, Ajay and Attri, Savita Verma and Bhattacharyya, Shalmoli and Das Radotra, Bishan and Medhi, Bikash},
title = {Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke},
journal = {Behavioural Brain Research},
year = {2023},
doi = {10.1016/j.bbr.2023.114471}
}
EUVIMED